- Report
- May 2025
- 196 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- May 2025
- 189 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- February 2025
- 200 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- July 2025
- 299 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Clinical Trials
- April 2025
- 220 Pages
Global
From €2197EUR$2,500USD£1,895GBP
- Report
- December 2024
- 171 Pages
Global
From €3471EUR$3,950USD£2,994GBP
- Report
- August 2024
- 168 Pages
Global
From €2197EUR$2,500USD£1,895GBP
- Report
- August 2024
- 49 Pages
Global
From €3510EUR$3,995USD£3,028GBP
- Report
- September 2024
- 343 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- June 2025
- 150 Pages
Global
From €2372EUR$2,699USD£2,046GBP
- Report
- May 2025
- 200 Pages
Global
From €2188EUR$2,490USD£1,887GBP
- Report
- August 2024
- 200 Pages
Global
From €2188EUR$2,490USD£1,887GBP
- Report
- March 2025
- 175 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- April 2025
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- April 2025
- 133 Pages
Global
From €13176EUR$14,995USD£11,365GBP
- Report
- September 2024
- 128 Pages
Global
From €13176EUR$14,995USD£11,365GBP
- Report
- April 2025
- 21 Pages
Global
From €13176EUR$14,995USD£11,365GBP
- Report
- May 2020
- 185 Pages
Global
From €3646EUR$4,150USD£3,145GBP
- Report
- March 2022
- 300 Pages
Global
From €4393EUR$5,000USD£3,790GBP
- Report
- January 2024
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects millions of people worldwide. It is characterized by difficulty breathing, coughing, and wheezing. COPD is typically treated with a combination of medications, including bronchodilators, inhaled corticosteroids, and antibiotics. The COPD drug market is a subset of the larger respiratory drug market, which includes drugs used to treat asthma, allergies, and other respiratory conditions.
The COPD drug market is highly competitive, with a variety of companies offering different types of medications. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, and Merck. These companies offer a range of COPD medications, including bronchodilators, inhaled corticosteroids, and antibiotics. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of these medications. Show Less Read more